Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
NEWS & FEATURES
Niraparib Extends Time Without Symptoms in Ovarian Cancer
Phase 3 JAVELIN Ovarian Cancer Study Halted
FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma
Favorable Outcomes Seen in Long Term for ALLR3 Trial
Testosterone Replacement Slows Prostate Cancer Recurrence
Levoleucovorin Injection Recalled Due to Presence of Particulate Matter
Emotionally Responsive Virtual Coach Helps Address Patient Concerns in New Simulation
Acupressure Reduces Lasting Symptoms in Breast Cancer Survivors
Trazimera, a Biosimilar to Herceptin, Gets FDA Approval
First Cancer Immunotherapy Regimen Approved for Breast Cancer Treatment
Low-Dose Aspirin Does Not Cut Death From Prostate Cancer
FDA Warns of Unapproved, Misbranded Drugs Distributed by CanaRx to US Consumers
Robotically Assisted Devices Not Approved for Cancer Surgery
Herceptin Hylecta Approved for the Treatment of HER2-Overexpressing Breast Cancer
Single-Application FIT Moderately Sensitive, Specific for CRC
FDA: Thermography No Substitute for Mammograms
Lonsurf Gains Metastatic Gastric Cancer Indication
Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer
